Craft
  • Home
  •  / Sumitomo Pharma
Sumitomo Pharma

Sumitomo Pharma

Revenue

¥560 B

FY, 2022

Market Capitalization

¥421.9 B

2022-11-18

Sumitomo Pharma Summary

Company summary

Overview
Sumitomo Pharma (住友ファーマ株式会社) is a company that manufactures and sells pharmaceuticals, food additives, and veterinary medicines. It develops drugs to cover various therapeutic areas such as psychiatry, neurology, diabetes, oncology, etc. The company also provides coatings and personal care products.
Type
Public
Status
Active
Founded
1897
HQ
Tokyo, JP | view all locations
Website
https://www.sumitomo-pharma.com
Sectors

LocationsView all

20 locations detected

  • Tokyo, Tokyo HQ

    Japan

    13-1, Kyobashi 1-chome

  • Marlborough, MA

    United States

    84 Waterford Dr, Marlborough

  • Jiangsu

    China

    No.115 QingQiu Street

  • Shanghai, Shang Hai Shi

    China

    7th Floor, Tower A, China Overseas International Center, Lane 838, South Huangpi Road

  • Fukuoka, Fukuoka

    Japan

    8F, Kamiyo Hakata-chuo Building, 7-21

  • Hiroshima, Hiroshima

    Japan

    5F, Asahi Seimei Hiroshima Ebisucho Building, 4-21,

and 14 others

Sumitomo Pharma Financials

Summary financials

Revenue (Q1, 2023)
¥159.9B
Gross profit (Q1, 2023)
¥128.1B
Net income (Q1, 2023)
¥28.1B
Cash (Q1, 2023)
¥255.4B
EBIT (Q1, 2023)
¥14.6B
Enterprise value
$435.4B

Footer menu